NCT06916637View on ClinicalTrials.gov

Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Breast CancerBreast Cancer, HER2-Expression
Interventions
RADIATION

18F-HER2 Affibody PET scan

HER2 Affibody, labeled with PET radio-nuclide 18F will be used as a molecular imaging tracer for PET scan. All participants will undergo 18F-HER2 Affibody PET scan.

Trial Locations (1)

266000

RECRUITING

Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER